SKYE
Skye Bioscience, Inc. Common Stock
NASDAQ: SKYE · HEALTHCARE · BIOTECHNOLOGY
$0.88
-1.71% today
Updated 2026-04-30
Market cap
$22.94M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.30
Dividend yield
—
52W range
$1 – $6
Volume
0.6M
Skye Bioscience, Inc. Common Stock (SKYE) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $16243.00 | $339926.00 | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Revenue growth (YoY) | — | +1992.8% | -100.0% | — | — | — | — | — | — | — | — | — | — | — |
| Cost of revenue | $5356.00 | $131341.00 | — | $9953.00 | $14916.00 | $8038.00 | $1544.00 | $1462.00 | $1872.00 | $34131.00 | $114998.00 | $124251.00 | $298640.00 | $723352.00 |
| Gross profit | $10887.00 | $208585.00 | — | $-9953.00 | $-14916.00 | $-8038.00 | $-1544.00 | $-1462.00 | $-1872.00 | $-34131.00 | $-114998.00 | $-124251.00 | $-298640.00 | $-723352.00 |
| Gross margin | 67.0% | 61.4% | — | — | — | — | — | — | — | — | — | — | — | — |
| R&D | — | — | $227500.00 | $576093.00 | $939040.00 | $311302.00 | $329966.00 | $2.24M | $1.94M | $2.93M | $6.01M | $5.82M | $18.70M | $42.36M |
| SG&A | $6374.00 | $120403.00 | $2.50M | $3.74M | $3.53M | $3.55M | $4.36M | $4.39M | $4.34M | $4.92M | $6.09M | $7.85M | $17.73M | $15.80M |
| Operating income | $4117.00 | $-7242.00 | $-2.73M | $-4.32M | $-4.47M | $-3.86M | $-4.69M | $-6.63M | $-6.29M | $-7.85M | $-18.31M | $-34.74M | $-30.19M | $-58.16M |
| Operating margin | 25.3% | -2.1% | — | — | — | — | — | — | — | — | — | — | — | — |
| EBITDA | $4755.00 | $-7242.00 | — | — | — | $-3.85M | $-4.69M | $2.04M | $-5.85M | $-7.72M | $-18.70M | $-36.62M | $-25.29M | $-57.44M |
| EBITDA margin | 29.3% | -2.1% | — | — | — | — | — | — | — | — | — | — | — | — |
| EBIT | $4117.00 | $-1631.00 | $-2.73M | $-4.32M | $-4.47M | $-3.09M | $-4.69M | $2.04M | $-5.85M | $-7.75M | $-18.81M | $-36.74M | $-25.59M | $-58.16M |
| Interest expense | $638.00 | $2151.00 | — | $522335.00 | $0.00 | $667.00 | $94763.00 | $1.00M | $706385.00 | $767511.00 | $663774.00 | $906270.00 | $967602.00 | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $4509.00 | $-120403.00 | $-2.73M | $-4.84M | $-3.18M | $-3.09M | $-19.19M | $1.05M | $-6.56M | $-8.52M | $-19.48M | $-37.64M | $-26.57M | $-55.92M |
| Net income growth (YoY) | — | -2770.3% | -2170.7% | -77.1% | +34.4% | +2.6% | -520.4% | +105.5% | -723.7% | -29.9% | -128.6% | -93.2% | +29.4% | -110.5% |
| Profit margin | 27.8% | -35.4% | — | — | — | — | — | — | — | — | — | — | — | — |